Literature DB >> 10997988

Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene.

V Picard1, A Bura, J Emmerich, M Alhenc-Gelas, C Biron, L L Houbouyan-Reveillard, P Molho, A Labatide-Alanore, P Sié, P Toulon, E Verdy, M Aiach.   

Abstract

We have investigated the molecular bases of familial antithrombin deficiency in eight French families. Eight mutations in the antithrombin coding exons were identified, seven of which were novel mutations. In all cases, individuals were heterozygous for the mutation. We found two small frameshift deletions in exon 3a, leading to type I deficiency. Five missense mutations in exons 3b or 5 also caused type I deficiency and their potential consequences on the antithrombin three-dimensional structure were analysed. The last mutation in exon 4 was associated with a type II 'reactive site' deficiency: a dysfunctional antithrombin that is affected in its interaction with thrombin was present in circulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997988     DOI: 10.1046/j.1365-2141.2000.02245.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Genotype phenotype correlation in a pediatric population with antithrombin deficiency.

Authors:  Mirjana Kovac; Gorana Mitic; Iva Djilas; Milos Kuzmanovic; Olivera Serbic; Danijela Lekovic; Branko Tomic; Zsuzsanna Bereczky
Journal:  Eur J Pediatr       Date:  2019-07-29       Impact factor: 3.183

2.  Two novel gene mutations in type I antithrombin deficiency.

Authors:  K Niiya; T Kiguchi; H Dansako; K Fujimura; T Fujimoto; K Iijima; M Tanimoto; M Harada
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

3.  Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities.

Authors:  Sonia Águila; Gonzalo Izaguirre; Irene Martínez-Martínez; Vicente Vicente; Steven T Olson; Javier Corral
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.